Both in Pharmaceuticals
BioMarin Pharmaceuticals vs Cytokinetics
Over the past year BMRN returned +8.7% and CYTK returned +3.3%; their daily moves had a correlation of 0.18.
BMRN +8.7% CYTK +3.3%Growth of $1, one year, split-adjusted
| Metric | BMRN | CYTK |
|---|---|---|
| Price | $57.44 | $62.03 |
| Market cap | $11.12B | $8.62B |
| Today | −1.83% | −1.52% |
| 1 month | +0.5% | −5.4% |
| 6 months | +3.6% | −6.1% |
| Year to date | −3.3% | −2.4% |
| 1 year | +10.7% | −0.4% |
| Revenue growth (YoY) | +19.9% | −57.1% |
| Gross margin | 79.5% | 90.5% |
| Net margin | 4.5% | −694.4% |
| P/E (TTM) | 152.4× | — |
| Price / sales | 3.3× | 127.4× |
| Net cash | -$3.31B | $18.6M |
| Dividend yield | — | — |
| Volatility (60d) | 30.6% | 31.7% |
| Short % of float | 6.2% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).